RT Journal Article SR Electronic T1 AI-Driven CT-based quantification, staging and short-term outcome prediction of COVID-19 pneumonia JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.04.17.20069187 DO 10.1101/2020.04.17.20069187 A1 Guillaume Chassagnon A1 Maria Vakalopoulou A1 Enzo Battistella A1 Stergios Christodoulidis A1 Trieu-Nghi Hoang-Thi A1 Severine Dangeard A1 Eric Deutsch A1 Fabrice Andre A1 Enora Guillo A1 Nara Halm A1 Stefany El Hajj A1 Florian Bompard A1 Sophie Neveu A1 Chahinez Hani A1 Ines Saab A1 Aliénor Campredon A1 Hasmik Koulakian A1 Souhail Bennani A1 Gael Freche A1 Aurelien Lombard A1 Laure Fournier A1 Hippolyte Monnier A1 Téodor Grand A1 Jules Gregory A1 Antoine Khalil A1 Elyas Mahdjoub A1 Pierre-Yves Brillet A1 Stéphane Tran Ba A1 Valérie Bousson A1 Marie-Pierre Revel A1 Nikos Paragios YR 2020 UL http://medrxiv.org/content/early/2020/04/22/2020.04.17.20069187.abstract AB Chest computed tomography (CT) is widely used for the management of Coronavirus disease 2019 (COVID-19) 49 pneumonia because of its availability and rapidity1–3. The standard of reference for confirming COVID-19 relies on microbiological tests but these tests might not be available in an emergency setting and their results are not immediately available, contrary to CT. In addition to its role for early diagnosis, CT has a prognostic role by allowing visually evaluating the extent of COVID-19 lung abnormalities4, 5. The objective of this study is to address prediction of short-term outcomes, especially need for mechanical ventilation. In this multi-centric study, we propose an end-to-end artificial intelligence solution for automatic quantification and prognosis assessment by combining automatic CT delineation of lung disease meeting expert’s performance and data-driven identification of biomarkers for its prognosis. AI-driven combination of variables with CT-based biomarkers offers perspectives for optimal patient management given the shortage of intensive care beds and ventilators6, 7.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A